Towards targeting of shared mechanisms of cancer metastasis and therapy resistance

F Weiss, D Lauffenburger, P Friedl - Nature Reviews Cancer, 2022 - nature.com
Resistance to therapeutic treatment and metastatic progression jointly determine a fatal
outcome of cancer. Cancer metastasis and therapeutic resistance are traditionally studied as …

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer

RB Birge, S Boeltz, S Kumar, J Carlson… - Cell Death & …, 2016 - nature.com
Apoptosis is an evolutionarily conserved and tightly regulated cell death modality. It serves
important roles in physiology by sculpting complex tissues during embryogenesis and by …

Immune signaling in neurodegeneration

TR Hammond, SE Marsh, B Stevens - Immunity, 2019 - cell.com
Neurodegenerative diseases of the central nervous system progressively rob patients of
their memory, motor function, and ability to perform daily tasks. Advances in genetics and …

Giving AXL the axe: targeting AXL in human malignancy

CM Gay, K Balaji, LA Byers - British journal of cancer, 2017 - nature.com
The receptor tyrosine kinase AXL, activated by a complex interaction between its ligand
growth arrest-specific protein 6 and phosphatidylserine, regulates various vital cellular …

AXL-mediated productive infection of human endothelial cells by Zika virus

S Liu, LJ DeLalio, BE Isakson, TT Wang - Circulation research, 2016 - ahajournals.org
Rationale: The mosquito-borne Zika virus (ZIKV) is now recognized as a blood-borne
pathogen, raising an important question about how the virus gets into human bloodstream …

The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation

AM Grabiec, T Hussell - Seminars in immunopathology, 2016 - Springer
Acute and chronic inflammatory responses in the lung are associated with the accumulation
of large quantities of immune and structural cells undergoing apoptosis, which need to be …

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non–Small Cell Lung Cancer

N Okura, N Nishioka, T Yamada… - Clinical Cancer …, 2020 - aacrjournals.org
Purpose: Currently, an optimal therapeutic strategy comprising molecularly targeted agents
for treating EGFR-mutated non–small cell lung cancer (NSCLC) patients with acquired …

TAM receptors, Phosphatidylserine, inflammation, and Cancer

T Burstyn-Cohen, A Maimon - Cell Communication and Signaling, 2019 - Springer
The numerous and diverse biological roles of Phosphatidylserine (PtdSer) are featured in
this special issue. This review will focus on PtdSer as a cofactor required for stimulating …

Systems Biology of the Cancer Cell

KA Janes, MJ Lazzara - Annual Review of Biomedical …, 2024 - annualreviews.org
Questions in cancer have engaged systems biologists for decades. During that time, the
quantity of molecular data has exploded, but the need for abstractions, formal models, and …

[HTML][HTML] AXL receptor tyrosine kinase as a promising therapeutic target directing multiple aspects of cancer progression and metastasis

MA Goyette, JF Côté - Cancers, 2022 - mdpi.com
Simple Summary Metastasis is a complex process that requires the acquisition of certain
traits by cancer cells as well as the cooperation of several non-neoplastic cells that populate …